Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP786378.RAsQ6vjqtHtgGMlnd6vHVGsLfP19fwQ9SJ5xZqnpbyJSY130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP786378.RAsQ6vjqtHtgGMlnd6vHVGsLfP19fwQ9SJ5xZqnpbyJSY130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP786378.RAsQ6vjqtHtgGMlnd6vHVGsLfP19fwQ9SJ5xZqnpbyJSY130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP786378.RAsQ6vjqtHtgGMlnd6vHVGsLfP19fwQ9SJ5xZqnpbyJSY130_provenance.
- NP786378.RAsQ6vjqtHtgGMlnd6vHVGsLfP19fwQ9SJ5xZqnpbyJSY130_assertion description "[Recently completed experimental animal studies, human biomarker data, vascular imaging studies, and genome-wide atherosclerosis studies provide the rationale for proceeding with clinical outcome trials directed at inhibition of secretory phospholipase A(2) and lipoprotein-associated phospholipase A(2).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP786378.RAsQ6vjqtHtgGMlnd6vHVGsLfP19fwQ9SJ5xZqnpbyJSY130_provenance.
- NP786378.RAsQ6vjqtHtgGMlnd6vHVGsLfP19fwQ9SJ5xZqnpbyJSY130_assertion evidence source_evidence_literature NP786378.RAsQ6vjqtHtgGMlnd6vHVGsLfP19fwQ9SJ5xZqnpbyJSY130_provenance.
- NP786378.RAsQ6vjqtHtgGMlnd6vHVGsLfP19fwQ9SJ5xZqnpbyJSY130_assertion SIO_000772 22802388 NP786378.RAsQ6vjqtHtgGMlnd6vHVGsLfP19fwQ9SJ5xZqnpbyJSY130_provenance.
- NP786378.RAsQ6vjqtHtgGMlnd6vHVGsLfP19fwQ9SJ5xZqnpbyJSY130_assertion wasDerivedFrom befree-20150227 NP786378.RAsQ6vjqtHtgGMlnd6vHVGsLfP19fwQ9SJ5xZqnpbyJSY130_provenance.
- NP786378.RAsQ6vjqtHtgGMlnd6vHVGsLfP19fwQ9SJ5xZqnpbyJSY130_assertion wasGeneratedBy ECO_0000203 NP786378.RAsQ6vjqtHtgGMlnd6vHVGsLfP19fwQ9SJ5xZqnpbyJSY130_provenance.
- befree-20150227 importedOn "2015-02-27" NP786378.RAsQ6vjqtHtgGMlnd6vHVGsLfP19fwQ9SJ5xZqnpbyJSY130_provenance.